docusate
Jump to navigation
Jump to search
Introduction
Epidemiology
- multi-state outbreak of Burkholderia cepacia infection from liquid docusate[2]
Indications
- constipation (hard stools)
Contraindications
- in patients with serious illness docusate of no benefit
- CDC & FDA recommend against using any liquid docusate product[4]
More general terms
More specific terms
Component of
- docusate/phenolphthalein
- docusate/ferrous fumarate
- benzocaine/docusate
- casanthranol/docusate (Peri-Colace)
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ 2.0 2.1 Centers for Disease Control & Prevention (CDC). Healthcare-associated Infections. July 8, 2016 Multistate Outbreak of Burkholderia cepacia Infections https://www.cdc.gov/hai/outbreaks/b-cepacia/index.html
- ↑ Tarumi Y, Wilson MP, Szafran O, Spooner GR. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage. 2013 Jan;45(1):2-13. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22889861
- ↑ 4.0 4.1 Brooks M FDA Warns Against Use of Any Liquid Product From PharmaTech Medscape - Aug 09, 2017. http://www.medscape.com/viewarticle/883981
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 19. American College of Physicians, Philadelphia 2021